UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.122

Sortiert nach

The NTCP‐inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics

Clinical pharmacology and therapeutics, 2018-02, Vol.103 (2), p.341-348

2018

Link zum Volltext

Verfügbarkeit prüfen

Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium

Clinical pharmacology and therapeutics, 2018-11, Vol.104 (5), p.803-817

2018

Link zum Volltext

Verfügbarkeit prüfen

Racial/ethnic differences in drug disposition and response: Review of recently approved drugs

Clinical pharmacology and therapeutics, 2015-03, Vol.97 (3), p.263-273

2015

Link zum Volltext

Verfügbarkeit prüfen

Transporters and drug therapy: Implications for drug disposition and disease

Clinical pharmacology and therapeutics, 2005-09, Vol.78 (3), p.260-277

2005

Link zum Volltext

Verfügbarkeit prüfen

Machine learning approaches for predicting disposition of asthma and COPD exacerbations in the ED

The American journal of emergency medicine, 2018-09, Vol.36 (9), p.1650-1654

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Clinical pharmacology and therapeutics, 2008-08, Vol.84 (2), p.248-253

2008

Link zum Volltext

Verfügbarkeit prüfen

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

Clinical pharmacology and therapeutics, 2007-07, Vol.82 (1), p.33-40

2007

Link zum Volltext

Verfügbarkeit prüfen

Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics

British journal of pharmacology, 2020-05, Vol.177 (10), p.2215-2239

2020

Link zum Volltext

Verfügbarkeit prüfen

The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition

Clinical pharmacology and therapeutics, 2016-11, Vol.100 (5), p.489-499

Wang, J

2016

Link zum Volltext

Verfügbarkeit prüfen

Does Power Magnify the Expression of Dispositions?

Psychological science, 2012-05, Vol.23 (5), p.475-482

2012

Link zum Volltext

Verfügbarkeit prüfen

CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

Clinical pharmacology and therapeutics, 2006-11, Vol.80 (5), p.457-467

2006

Link zum Volltext

Verfügbarkeit prüfen

Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates

Clinical pharmacology and therapeutics, 2019-03, Vol.105 (3), p.719-729

2019

Link zum Volltext

Verfügbarkeit prüfen

Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin

Clinical pharmacology and therapeutics, 2008-11, Vol.84 (5), p.559-562

2008

Link zum Volltext

Verfügbarkeit prüfen

Skeletal Muscle and Fat Mass Indexes Predict Discharge Disposition after Radical Cystectomy

The Journal of urology, 2019-12, Vol.202 (6), p.1143-1149

2019

Link zum Volltext

Verfügbarkeit prüfen

Roles of organic anion transporter 2 and equilibrative nucleoside transporter 1 in hepatic disposition and antiviral activity of entecavir during non‐pregnancy and pregnancy

British journal of pharmacology, 2019-09, Vol.176 (17), p.3236-3249

2019

Link zum Volltext

Verfügbarkeit prüfen

National Complication Rates and Disposition After Posterior Lumbar Fusion for Acquired Spondylolisthesis

Spine (Philadelphia, Pa. 1976), 2009-08, Vol.34 (18), p.1963-1969

2009

Link zum Volltext

Verfügbarkeit prüfen

Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study

Clinical pharmacology and therapeutics, 2019-03, Vol.105 (3), p.761-768

2019

Link zum Volltext

Verfügbarkeit prüfen

Disposition of Acetaminophen at 4, 6, and 8 g day for 3 Days in Healthy Young Adults

Clinical pharmacology and therapeutics, 2007-06, Vol.81 (6), p.840-848

2007

Link zum Volltext

Verfügbarkeit prüfen

Regional Variation in Mortality, Length of Stay, Cost and Discharge Disposition among Patients Admitted for Heart Failure in the United States

The American journal of cardiology, 2017-09, Vol.120 (5), p.817-824

2017

Link zum Volltext

Verfügbarkeit prüfen

UGT1A128 polymorphism as a determinant of irinotecan disposition and toxicity

The pharmacogenomics journal, 2002, Vol.2 (1), p.43-47

2002

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans

Clinical pharmacology and therapeutics, 2008-07, Vol.84 (1), p.95-103

2008

Link zum Volltext

Verfügbarkeit prüfen

Associations Between ABCC2 Polymorphisms and Cisplatin Disposition and Efficacy

Clinical pharmacology and therapeutics, 2012-06, Vol.91 (6), p.1022-1026

2012

Link zum Volltext

Verfügbarkeit prüfen

Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans

Clinical pharmacology and therapeutics, 2004-12, Vol.76 (6), p.607-617

2004

Link zum Volltext

Verfügbarkeit prüfen

A variety of combinatorially linkable units as disposition:† from a giant icosahedral Keplerate to multi-functional metal–oxide based network structures

Chemical communications (Cambridge, England), 1999-01 (15), p.1347-1358

1999

Link zum Volltext

Verfügbarkeit prüfen

Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans

Clinical pharmacology and therapeutics, 2004-09, Vol.76 (3), p.192-200

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.122

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

KollektionSingle Journals

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.100)
Mit Volltextzugriff
(1.802)

Publikationsform

Artikel
(2.122)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The NTCP‐inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics

Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium

Racial/ethnic differences in drug disposition and response: Review of recently approved drugs

Transporters and drug therapy: Implications for drug disposition and disease

Machine learning approaches for predicting disposition of asthma and COPD exacerbations in the ED

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics

The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition

Does Power Magnify the Expression of Dispositions?

CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates

Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin

Skeletal Muscle and Fat Mass Indexes Predict Discharge Disposition after Radical Cystectomy

Roles of organic anion transporter 2 and equilibrative nucleoside transporter 1 in hepatic disposition and antiviral activity of entecavir during non‐pregnancy and pregnancy

National Complication Rates and Disposition After Posterior Lumbar Fusion for Acquired Spondylolisthesis

Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study

Disposition of Acetaminophen at 4, 6, and 8 g day for 3 Days in Healthy Young Adults

Regional Variation in Mortality, Length of Stay, Cost and Discharge Disposition among Patients Admitted for Heart Failure in the United States

UGT1A128 polymorphism as a determinant of irinotecan disposition and toxicity

Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans

Associations Between ABCC2 Polymorphisms and Cisplatin Disposition and Efficacy

Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans

A variety of combinatorially linkable units as disposition:† from a giant icosahedral Keplerate to multi-functional metal–oxide based network structures

Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans

Aktive Filter

Suchergebnisse filtern